bleedingdisordersinchildren2021-210709092146 (1) (1).pptx

SumeraAhmad5 92 views 52 slides Aug 08, 2024
Slide 1
Slide 1 of 52
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52

About This Presentation

HEMOPHILIA, VON WILLEBRAND , ITP, VIT K DEF


Slide Content

Bleeding Disorders in Children Pathophysiology, Etiology, Clinical Features, Management Hemophilia, von Willebrand disease, ITP, VKDD, DR SUMERA AKRAM FCPS Pediatrics, CHPE, MRCPCH 1a SR DEPARTMENT OF PEDIATRIC MEDICINE SMC

Bleeding Disorders Pathophysiology

How is Hemostasis achieved ? Mechanisms to stop bleeding Vessel wall (vasoconstriction) Platelets (plug formation) Coagulation proteins (fibrin clot formation) Mechanisms to stop coagulation process Anti- coagulant proteins (Protein C, Protein S, Antithrombin III) Fibrinolytic system (Plasminogen)

Coagulation Factors I=Fibrinogen II= Prothrombin V= Labile factor,Proaccelerin ( para hemophilia) VII= Stable factor/ Proconvertin (HEMOPHILIA A) VIII= Antihemophilic factor(HEMOPHILIA B) IX= Christmas factor X= Stuart- prower factor( hemophila C) XI= Plasma thromboplastin antecedent XII= Hageman factor XIII= Fibrin stablizing factor

K K Vitamin K is an essential factor to a hepatic gamma- glutamyl carboxylase that adds a carboxyl group to glutamic acid residues on factors II, VII, IX and X, as well as Protein S, Protein C and Protein Z. The main role of protein Z appears to be the degradation of factor Xa . This is done by protein Z- related protease inhibitor (ZPI), but the reaction is accelerated 1000- fold by the presence of protein Z K K K Platelets Vascular Cells K Advances in Vascular Medicine 8 September 2014, Article ID 542034, 4 pages http://dx.doi.org/10.1155/2014/542034 and wikipedia.org/coagulation

Bleeding Disorders Etiology

Causes of Abnormal Bleeding

Causes of Abnormal Bleeding Vascular defects Vessel wall defects - - HSP vasculitis Extra - Vascular (supporting tissue) defects - - Hereditary Collagen disorders - - Collagen atrophy Corticosteroids adverse effects Old age (senile purpura) - - Scurvy (Vit C deficiency)

Causes of Abnormal Bleeding Platelets defects – Decreased Platelets Thrombocytopenia - - Production decreased - Aplastic anemia, Acute Leukemia, Folic acid and B12 deficiency) - - Consumption increased - (DIC, HUS) - - Destruction increased – - - ITP (Idiopathic Thrombocytopenic Purpura) - - SLE Platelet Function Defects - - Bernard Soulier syndrome - - Glanzmann Thromboasthenia - - Uremia

Causes of Abnormal Bleeding Coagulation abnormalities Intrinsic Pathway - - Hemophilia - - von Willebrand disease Extrinsic Pathway - - Factor VII deficiency (very rare) Intrinsic + Extrinsic Pathway - - Liver disease - - Vitamin K deficiency

Bleeding Disorders Clinical Features

Bleeding Disorders - Clinical Features Trauma / Injury bleeds – bruises, prolonged bleeding Skin bleeds – Petechiae, Purpura Mucosal bleeds – Epistaxis, Oral bleeds Tissue bleeds – Muscle bleeds, Joint bleeds (Hemarthrosis) Life- threatening bleeds – Intracranial hemorrhage

Bleeding Disorders – Assessment Patient History History Age of onset Duration of bleeding Site of bleeding Severity of bleeds Obvious cause of bleeds – Trauma, Spontaneous Past History – bleeding after circumcision Family History of Bleeding disorder – parents, siblings, uncles , males, males + females

Bleeding Disorders – Assessment Examination Examination Local injury examination Skin Nose, Oral cavity, Throat Lymph nodes Liver, Spleen Complications of Bleeds Pallor - Anemia Vitals – Pulse, Respiration, Blood Pressure, SaO2

Bleeding Disorders – Diagnosis

Bleeding Disorders Investigations

Bleeding Disorders – Investigations Initial investigations – CBC, Platelet Count, Blood peripheral film PT – Prothrombin Time (Extrinsic pathway) APTT – Activated Partial Thromboplastin Time (Intrinsic pathway)

Bleeding Disorders – Investigations Subsequent investigations – as needed Bleeding time – prolonged in Vascular or Platelet defects Platelet aggregation tests – Platelet function tests Mixing studies – normal plasma, adsorbed plasma, aged serum Coagulation Factor levels

Case Scenario

Case Scenario A 5 years old boy is brought to the ER with swollen and painful right ankle after a minor fall. There is history of prolonged bleeding after circumcision in the child. Minor injuries often result in bruises On exam, he is looks pale. Right ankle is swollen and tender. What investigations should be performed ? What is the most likely diagnosis ?

Case Scenario His investigations Hb 7.6 gm/dl, TLC 5,600, Platelets 2,24000 PT = 14 sec (N = 10 – 13 s) APTT = 88 sec (N = 30 – 35 s) Factor VIII level = 8 % of normal

Hemophilia Epidemiology, Etiology, Pathophysiology Clinical Features, Management

Hemophilia – Epidemiology and Etiology

Hemophilia – Clinical Presentation Subcutaneous bleeds (bruises) after minor trauma Bleeding after circumcision (30 % of patients) Prolonged bleeding after minor injuries Bleeding in Joints (Hemarthrosis) Bleeding in Muscles (Hematoma)

Hemophilia – Lab Investigations

Hemophilia – Classification

Hemophilia – Management Prevention Avoid Trauma – household, roadside, sports Avoid Aspirin and NSAIDs Prophylactic factor transfusion: Keep Factor VIII level more than 40 % Factor VIII concentrates ( lyophylised ) given by IV dose on alternate days

Hemophilia – Management Manage Active Bleeds Raise and keep Factor VIII level at 40 – 100 % for 3 – 7 days Desmopressin – Releases Factor VIII from endothelium Tranexamic acid – Inhibits Fibrinolytic system FFP (Fresh Frozen Plasma) – provides Factor VIII Cryoprecipitate – concentrated Factor VIII from plasma Factor VIII concentrates (recombinant) – 250 units / vial

VWD Von Willebrand Disease Epidemiology, Etiology, Pathophysiology Clinical Features, Management

Von Willebrand Disease – Epidemiology and Etiology Most common inherited bleeding disorder Seen in males and females equally Autosomal Dominant

Pathophysiology of von Willebrand disease: Von Willebrand Factor synthesized in WPB bodies of endothelial cells and megakaryocytes. Binds to receptors (gP-1b) on platelets . Primary hemostasis: normal vWF Multimers bind with platelet glycoprotein 1b on one side and sub endothelial collagen on other side – stable plug formation. SECONDARY HEMOSTASIS: Vwf Aslo binds to VIII and prevent its destruction. Deficiency of Von Willebrand Factor results in: Impaired Platelet adhesion Low blood levels of Factor VIII

CLASSIFICATION OF vWD

Von Willebrand Disease Clinical Presentation

Von Willebrand Disease – Lab Investigations CBC – shows severity of blood loss . Normal platelets except in type 2B PT – Prothrombin Time – Normal APTT – Activated Partial Thromboplastin Time – Prolonged especially in type 3, normal in type 1 Bleeding time – prolonged Platelet aggregation study- no response to Ristocetin ( like BSS) Von Willebrand Factor Antigen assay (vWF:Ag) – low Von Willebrand Factor multimer analysis for dx of type 2 subtypes

Von Willebrand Disease – Management Active Bleeds Prevention: Avoid Trauma – household, roadside, sports Avoid Aspirin and NSAIDs Treatment: Desmopressin ( analogue of ADH ) – Releases von Willebrand Factor from storage sites- IV , SC, Nasal spray Tranexamic acid – Inhibits Fibrinolytic system FFP (Fresh Frozen Plasma) – provides von Willebrand Factor Von Willebrand Factor concentrates

ITP Idiopathic Thrombocytopenic Purpura Epidemiology, Etiology, Pathophysiology Clinical Features, Management

ITP (Idiopathic Thrombocytopenic Purpura) Epidemiology and Etiology Seen in Children – 1: 20,000 Onset is often acute Pathophysiology: Immune mediated destruction of Platelets Usually occurs as a Post – viral illness , inflammation, autoimmune- antibodies bind to platelets and make them prone to destruction by macrophages andRES spleen- also suppresuve effect of these antibodies on magakaryocytes in BM- increades destruction and decreseard production.

Characteristics of ITP: Isloated thrombocytopenia( platelets count < 100x109/L , often < 20x 109 / L) A healthy child with no concerning features on history and ex Normal CBC and peripheral film ex ( except low platelets) Remember: alternate diagnosis if – severe pallor, jaundice, hepatosplenomegaly and lymphadenopathy , bone pains, anorexia, wt loss, fever, rash, arthritis, mouth ulcers, family history, liver, spleen , lymph nodes.

ITP (Idiopathic Thrombocytopenic Purpura) Clinical Presentation usually preceded by 3weeks with viral infection , sometimes post vaccination ITP (Idiopathic Thrombocytopenic Purpura) usually presents with p etechiae and bruising on skin - mild75-80% Epistaxis and gum Bleeding -moderate 15-20% Prolonged epistaxis. Gut bleed, muscle or joint – severe 3-5% Life threatening bleed like intracranial< 1%

ITP (Idiopathic Thrombocytopenic Purpura) Lab Investigations CBC – Thrombocytopenia Platelet Count 20,000 – 40,000 Peripheral smear: manual platelet count and platelet morphology ( large platelets in BSS) AND rule out abnormal cells. PT /APTT – Normal Bleeding time – prolonged Work up to rule out secondary ITP: IMMUNOLOGIC( RA, ANA, anti DsDNA, complement levels) Viral serology( hep B, C, HIV , CMV, EBV) Bone Marrow Exam – Megakaryocytes increased and to rule out other diagnosis

ITP (Idiopathic Thrombocytopenic Purpura) Differential Diagnosis Acute Leukemia : sick , pancytopenia hepatosplenomegaly and lymphadenopathy APLASTIC ANEMIA: low platelets may be the initial manifestation of aplastic anemia preceded by pancytopenia B12 and Folate def Hemolytic uremic syndrome: diarrhea, low HB%, fragmented cells in smear, deranged RFT TTP: rare in children Platelet function disorder: Bernard soulier syndrome SLE (Systemic Lupus Erythematosus) Post – Viral Infection Thrombocytopenia Drugs (adverse effect) – Sulphonamides, Carbamazepine Congenital Hypoplastic Anemia ( TAR Fanconi Anemia)

CLINICAL CLASSIFICATION AND NATURAL HISTROY OF ITP

Management flow chart for acute and chronic ITP

Vitamin K deficiency disorders Epidemiology, Etiology, Pathophysiology Clinical Features, Management

Vitamin K deficiency disorders Epidemiology and Etiology Seen in newborns or infancy Deficiency of Vitamin K is in the diet or due to Malabsorption Deficiency of Vitamin K impairs production of Coagulation Factors II, VII, IX, X Onset is often acute Usually presents with Purpura (spontaneous skin bleeds)

Vitamin K deficiency disorders Etiology Exclusive breastfeeding Liver disease Biliary atresia Severe malnutrition Malabsorption (Fat soluble Vitamin) Prolonged Antibiotic use

Vitamin K deficiency disorders Clinical Presentation Purpura (skin bleeds) Mucosal bleeds (oral cavity) Hematemesis (blood in vomit) Melena (blood in stool) Hematuria (blood in urine) Umbilical bleeding Intracranial hemorrhage

Vitamin K deficiency disorders Lab Investigations CBC – Anemia due to bleeding Platelet Count = Normal PT – Prothrombin Time – Prolonged APTT – Activated Partial Thromboplastin Time – Prolonged

Vitamin K deficiency disorders Management Vitamin K IV dose (NO IM doses) Fresh frozen plasma (to provide preformed coagulation factors) Packed RBC transfusion (to correct anemia)

Vitamin K deficiency disorders Prevention VITAMIN K at BIRTH to every Newborn 1 mg IM at day 1 OR 1 mg ORAL at day 1, 7, 28 of life DOSES of Vitamin K Exclusive breast feeding (monthly) Malabsorption (monthly) Liver disease (weekly) Cholestasis (weekly)

It contains estimated 200 Billion Stars, the sun lies roughly 27,000 light-years from the centre of the galaxy. And there are estimated minimum 100 Billion Galaxies in the Universe.
Tags